Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Epilepsy × Dexmedetomidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Postoperative Nausea and Vomiting 1 Neurofibromatoses 1 Neoplasms 1 Hydrocephalus 1 Headache 1 Epilepsy 1 Brain Neoplasms 1 Benign Neoplasm of Vocal Fold - Glottis 1 Abdominal Neoplasms 1

Interventions

Everolimus 2 perampanel 1 clevidipine 1 Sirolimus 1 Sevoflurane 1 Propofol 1 Nitrous Oxide 1 Lidocaine 1 Immunoglobulins, Intravenous 1 Glycopyrrolate 1 Dexmedetomidine 1 Anticonvulsants 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed

40 enrolled 15 charts

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon ⚡